Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2026 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2026 USD ($) segment	Sep. 30, 2025 USD ($)
Segment Reporting [Abstract]
Number of operating segments | segment			1
Number of reportable segments | segment			1
Segment Reporting [Line Items]
Total research and development expenses	$ 49,810	$ 47,928	$ 177,167	$ 159,271
Total selling, general, and administrative expenses	70,071	70,106	208,013	204,566
Reportable Segment
Segment Reporting [Line Items]
Personnel compensation and related costs	16,678	21,539	57,861	68,067
Licensing fees	0	0	37,000	19,997
CROs/CMOs/Investigators expenses and other costs	33,132	26,389	82,306	71,207
Total research and development expenses	49,810	47,928	177,167	159,271
Clinical programs	25,902	18,179	71,782	63,236
Pre-Clinical programs	3,296	1,982	34,621	10,365
Unallocated research and development expenses	20,612	27,767	70,764	85,670
Personnel compensation and related costs	39,210	41,320	124,978	124,642
Other costs	30,861	28,786	83,035	79,924
Total selling, general, and administrative expenses	70,071	70,106	208,013	204,566
Selling and marketing expenses	51,425	47,179	146,419	135,882
General and administrative expenses	$ 18,646	$ 22,927	$ 61,594	$ 68,684